BioMed Central (United Kingdom)

BioMed Central (United Kingdom)

BioMed Central is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioMed Central (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

93%


Total
Publications

515


Total Open
Publications

480


Total
Citations

7.7K


Open Access
Percentage

93%


Total
Publications

515


Total Open
Publications

480


Total
Citations

7.7K

Wikipedia

Website

download

Breakdown

11% 81% 1% 7%

Publisher Open

11%

Both

81%

Other Platform Open

1%

Closed

7%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

77%OA Journal

OA Journal 77%

364

Hybrid 14%

67

No Guarantees 9%

41

Other Platform Open

Domain 97%

411

Institution 4%

16

Other Internet 2%

8

Public 1%

5

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
410
Europe PMC
Domain
73
University College London - UCL Discovery
Institution
12
Semantic Scholar
Public
3
University of Nottingham - Repository@Nottingham
Institution
2
University of Naples Federico II - E-LIS Repository
Other Internet
2
Temple University - TUScholarShare
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
2
Le Centre pour la Communication Scientifique Directe - HAL - memSIC
Other Internet
2
Zenodo
Public
1
1 / 3

Data updated 7 April 2025

Share

Share

Share